Form 4: OneMedNet CEO Green Boosts Stake with Equity Grants
Insider Transaction Report
OneMedNet CEO Aaron Green reported significant acquisitions of common stock through restricted stock unit grants and the conversion of a senior secured convertible note.
Summary
- Aaron Green, CEO and Director of OneMedNet Corp, acquired a total of 1,330,425 shares of common stock through various transactions.
- This includes 45,000 restricted stock units (RSUs) granted on January 19, 2024, for 2024 director compensation, which vested on December 31, 2024.
- An additional 240,425 shares were acquired on June 17, 2025, from the conversion of a Senior Secured Convertible Note (PIPE Note) at a price of $1.14 per share.
- A substantial grant of 1,000,000 RSUs was made on November 24, 2025, as employment compensation for fiscal years 2024 and 2025, with a staggered vesting schedule.
- Another 45,000 RSUs were granted on November 26, 2025, for 2025 director compensation, vesting on December 31, 2025.
- Following these reported transactions, Aaron Green beneficially owns 1,930,425 shares of OneMedNet Corp common stock.
Sentiment
Score: 8
Explanation: The significant increase in insider ownership through RSU grants and convertible note conversion demonstrates strong confidence from the CEO in the company's future prospects and aligns his interests with long-term shareholder value. While RSUs are not direct cash purchases, they represent a substantial equity stake tied to future performance.
Positives
- Significant increase in insider ownership, aligning management's interests with shareholders.
- The grants of restricted stock units (RSUs) serve as long-term incentives for the CEO's continued service and performance.
- Conversion of the PIPE Note indicates a move from debt-like instruments to equity, potentially simplifying the capital structure.
Negatives
- A significant portion of the acquired shares (RSUs) were granted at a $0.00 price, meaning no direct cash investment by the CEO for these specific shares.
- The vesting of a large portion of the RSUs is contingent on continued service, which is a standard practice but also means the full benefit is not immediate.
Risks
- The value of the RSU grants and converted shares is subject to the future performance of OneMedNet Corp's stock price.
- Continued service is required for the vesting of RSUs, posing a risk to the full realization of the compensation if employment ceases.
Future Outlook
The significant RSU grants with multi-year vesting schedules indicate a long-term commitment of the CEO to the company's future performance and strategic direction, aligning his compensation with future shareholder value creation.
Industry Context
The use of restricted stock units (RSUs) and convertible notes as components of executive compensation and financing is a common practice across various industries, particularly in growth-oriented companies. This structure aims to align executive incentives with long-term company performance and shareholder interests.
Comparison to Industry Standards
- The granting of RSUs as a significant component of executive and director compensation is a standard practice, comparable to compensation structures seen in technology and healthcare companies of similar size, such as those utilizing equity incentive plans to attract and retain talent.
- The conversion of a Senior Secured Convertible Note (PIPE Note) is a typical mechanism for early-stage or growth companies to raise capital, often involving insider participation, similar to financing rounds observed in biotech or software development firms.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Incentive Plan Utilization | The reported RSU grants were made under the OneMedNet Corporation 2022 Equity Incentive Plan, indicating active use of the plan for executive and director compensation. | N/A | Reinforces the company's strategy to use equity-based compensation to align management and director incentives with shareholder interests. |
Related Party Transactions
- Aaron Green, as the reporting person and CEO, was one of the Purchasers of the Senior Secured Convertible Notes (PIPE Notes) issued on June 28, 2023, by the predecessor company, Data Knights Acquisition Corp.
Stakeholder Impact
- Shareholders: Increased alignment of CEO's interests with shareholders due to substantial equity holdings and long-term vesting schedules.
- Employees: The equity incentive plan provides a framework for attracting and retaining key talent, potentially benefiting other employees through similar programs.
Next Steps
- Continued vesting of 1,000,000 RSUs granted for employment compensation, with 47% vesting on January 1, 2026, 33% vesting quarterly in fiscal year 2026, and 20% vesting quarterly in fiscal year 2027.
- Monitoring of the company's performance and stock price, which will directly impact the value of the CEO's equity holdings.
Key Dates
| Date | Description |
|---|---|
| 2023-06-28 | Data Knights Acquisition Corp. (predecessor of issuer) and certain investors, including Aaron Green, entered into a securities purchase agreement for Senior Secured Convertible Notes (PIPE Notes). |
| 2024-01-19 | Grant of 45,000 Restricted Stock Units (RSUs) for 2024 director compensation. |
| 2024-11-07 | Maturity date of the PIPE Notes. |
| 2024-12-31 | Vesting date for 45,000 RSUs granted on January 19, 2024. |
| 2025-01-01 | Vesting start date for 1,000,000 RSUs granted as employment compensation. |
| 2025-06-17 | Conversion of 240,425 shares from Senior Secured Convertible Note. |
| 2025-11-24 | Grant of 1,000,000 Restricted Stock Units (RSUs) for 2024 and 2025 employment compensation. |
| 2025-11-26 | Grant of 45,000 Restricted Stock Units (RSUs) for 2025 director compensation. |
| 2025-12-31 | Vesting date for 45,000 RSUs granted on November 26, 2025. |
| 2026-01-01 | First anniversary of vesting start date for 1,000,000 RSUs, with 47% vesting. |
| 2026-12-31 | End of fiscal year 2026, during which 33% of 1,000,000 RSUs vest in equal quarterly installments. |
| 2027-12-31 | End of fiscal year 2027, during which 20% of 1,000,000 RSUs vest in equal quarterly installments. |
Keywords
OneMedNet, ONMD, Aaron Green, Form 4, Insider Transaction, Restricted Stock Units, RSU, Convertible Note, CEO Compensation, Equity Incentive Plan, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.